Genome‑wide ChIP‑seq data with a transcriptome analysis reveals the groups of genes regulated by histone demethylase LSD1 inhibition in esophageal squamous cell carcinoma cells-Reference-Cited by-同舟云学术

Genome‑wide ChIP‑seq data with a transcriptome analysis reveals the groups of genes regulated by histone demethylase LSD1 inhibition in esophageal squamous cell carcinoma cells

Published:2019-05-13 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Hoshino Isamu¹,Takahashi Masahiko¹,Akutsu Yasunori¹,Murakami Kentaro¹,Matsumoto Yasunori¹,Suito Hiroshi¹,Sekino Nobufumi¹,Komatsu Aki¹,Iida Keiko¹,Suzuki Takayoshi²,Inoue Itsuro³,Ishige Fumitaka⁴,Iwatate Yosuke⁴,Matsubara Hisahiro¹

Affiliation:

1. Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chuo‑ku, Chiba 260‑8670, Japan

2. Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kita‑ku, Kyoto 403‑8334, Japan

3. Division of Human Genetics, National Institute of Genetics, Mishima, Shizuoka 411‑8540, Japan

4. Department of Hepatobiliary and Pancreatic Surgery, Chiba Cancer Center, Chuo‑ku, Chiba 260‑8717, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting LSD1 in cancer: Molecular elucidation and recent advances;Cancer Letters;2024-08

2. A Quinquennial Review of Potent LSD1 Inhibitors Explored for the Treatment of Different Cancers, with Special Focus on SAR Studies;Current Medicinal Chemistry;2024-01

3. Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment;Oncology Reports;2021-09-08

4. The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal Cancer;Frontiers in Oncology;2021-05-11

5. Discovery of higenamine as a potent, selective and cellular active natural LSD1 inhibitor for MLL-rearranged leukemia therapy;Bioorganic Chemistry;2021-04